<table border="1" width="726" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Concomitant Drug</paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Effect on Concentration of Lamotrigine or Concomitant Drug</paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Clinical Comment</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Estrogen-containing oral contraceptive preparation containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel</paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph> </paragraph>
<paragraph>↓    Lamotrigine </paragraph>
<paragraph> </paragraph>
<paragraph> </paragraph>
<paragraph>↓    levonorgestrel</paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph> </paragraph>
<paragraph>Decreased lamotrigine levels approximately 50%. </paragraph>
<paragraph> </paragraph>
<paragraph>Decrease in levonorgestrel component by 19%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Carbamazepine (CBZ) and CBZ epoxide</paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>↓    Lamotrigine</paragraph>
<paragraph> </paragraph>
<paragraph> </paragraph>
<paragraph> </paragraph>
<paragraph>?    CBZ epoxide</paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Addition of carbamazepine decreases lamotrigine concentration approximately 40%.</paragraph>
<paragraph> </paragraph>
<paragraph>May increase CBZ epoxide levels.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Phenobarbital/Primidone </paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>↓    Lamotrigine </paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Decreased Lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Phenytoin (PHT)</paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>↓    Lamotrigine</paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Decreased Lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Rifampin</paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>↓    Lamotrigine</paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Decreased Lamotrigine AUC approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Valproate</paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>↑    Lamotrigine</paragraph>
<paragraph> </paragraph>
<paragraph> </paragraph>
<paragraph> </paragraph>
<paragraph> ?   valproate</paragraph>
<paragraph> </paragraph>
</td>
<td stylecode="Botrule Lrule Rrule Toprule">
<paragraph>Increased Lamotrigine concentrations slightly more than 2-fold. </paragraph>
<paragraph> </paragraph>
<paragraph>Decreased valproate concentrations an average of 25% over a 3-week period then stabilized in healthy volunteers; no change in controlled clinical trials in epilepsy patients.</paragraph>
</td>
</tr>
</tbody>
</table>